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Objective: To investigate the cross-cultural validity of inter-
national Dutch-English comparisons when using the Dutch 
Rivermead Mobility Index (RMI), and the intra-test reliabil-
ity and construct validity of the Dutch RMI.
Methods: Cross-cultural validity was studied in a combined 
data-set of Dutch and English patients undergoing rehabili-
tation after stroke, who were assessed with the Dutch ver-
sion of the RMI and the original English RMI, respectively. 
Mokken scale analysis was used to investigate unidimension-
ality, monotone homogeneity model fit, and differential item 
functioning between the Dutch and the English RMI. Intra-
test reliability and construct validity were studied in the 
Dutch patients by calculating the reliability coefficient and 
correlating the Dutch RMI and the Dutch Barthel Index.
Results: The RMI was completed for Dutch (n = 200) and 
English (n = 420) patients after stroke. The unidimensionality 
and monotone homogeneity model fit of the RMI were excel-
lent: combined Dutch-English data-set (coefficient H = 0.91); 
Dutch data-set (coefficient H = 0.93); English data-set (coef-
ficient H = 0.89). No differential item functioning was found 
between the Dutch and the English RMI. The intra-test reli-
ability of the Dutch RMI was excellent (coefficient ρ = 0.97). 
In a sub-sample of patients (n = 91), the Dutch RMI corre-
lated strongly with the Dutch Barthel Index (Spearman’s 
correlation coefficient ρ = 0.84). 
Conclusion: The Dutch RMI allows valid international 
Dutch-English comparisons, and has excellent intra-test re-
liability and construct validity.
Key words: cerebrovascular accident, quality of life, disability 
evaluation, psychometrics.
J Rehabil Med 2008; 40: 727–732
Correspondence address: Leo D. Roorda, Department of 
Rehabilitation Medicine and Psychology, Jan van Breemen 
Institute, Dr. J. van Breemenstraat 2, 1056 AB Amsterdam, The 
Netherlands. E-mail: l.roorda@janvanbreemen.nl
Submitted September 18, 2007; accepted May 19, 2008
INTRODUCTION
The past 25 years have seen the development of a large number 
of patient-reported outcome (PRO) instruments, and these 
instruments are being used increasingly in scientific research, 
with a growing emphasis on international applications (1). In-
ternational applications stem from the need to pool data across 
the nationality of respondents (e.g. for systematic reviews) and 
from increasing international research collaboration (2, 3).
The cross-national use of measurement instruments has cre-
ated a need for cross-culturally valid instruments for outcome 
assessment (3). Readers of international journals may assume 
that the effects of an intervention that has been applied in another 
country can be generalized to their own situation if the setting, 
the study population and the intervention at hand are comparable. 
For instance, they may assume that, if exercise therapy increases 
mobility by 5 points in Dutch patients after stroke (measured with 
the Dutch Rivermead Mobility Index (RMI)), exercise therapy 
will also increase mobility by 5 points in English patients after 
stroke (measured with the English RMI). However, this assump-
tion is based on the premise that the response of Dutch and Eng-
lish patients after stroke to the Dutch RMI and the English RMI, 
respectively, will be equivalent, and will depend on the patients’ 
level of mobility, and not on their nationality; furthermore, any 
changes in mobility will result in equivalent changes in the scores 
for these different instruments. This issue of the comparability 
of scores between different cultural (including language) groups 
can be addressed in cross-cultural validation studies (3).
The RMI (4) is a PRO instrument that measures mobility, an 
important aspect of daily functioning in patients after stroke, and is 
being used increasingly for international research in patients with 
stroke. The clinimetric properties of the original English version of 
the RMI are well known (4–7), and an increasing number of trans-
lations are available (8–10). However, as yet, no cross-cultural 
validation study has been carried out. From this perspective, we 
have recently made a Dutch translation of the RMI.
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The purpose of this study was to investigate the cross-cultural 
validity, the intra-test reliability and the construct validity 
of this Dutch RMI in patients undergoing rehabilitation after 
stroke.
METHODS
Patients
We recruited a cohort of patients in the Netherlands (further referred 
to as Dutch patients) with a definite diagnosis of stroke who had been 
admitted to a specialized department of a rehabilitation centre (Sint 
Maartenskliniek in Nijmegen). Two-hundred (94%) of the 212 patients 
after stroke who were admitted to the department between January 
2001 and January 2005 participated in the study. Twelve patients did 
not participate, mainly for logistic reasons due to the short length of 
their stay.
Data-sets from 3 different English studies were used to study cross-
cultural validity. The first study (11) concerned English patients living 
in the community with mobility problems more than one year after 
stroke, who participated in a randomized controlled trial assessing the 
effectiveness of physiotherapy. Of the potential 359 trial participants 
182 fulfilled the selection criteria, and 171 (93%) completed a base-
line assessment. Data on these 171 patients were used for the current 
study. The second study (12) concerned English patients with a clini-
cal diagnosis of stroke, admitted to an inpatient stroke rehabilitation 
unit, who participated in a randomized controlled trial assessing the 
effectiveness of the Oswestry standing frame. Of the 412 patients 
referred to the stroke unit, 167 fulfilled the inclusion criteria and 140 
(84%) participated in the study. Data on these 140 participants were 
used in the current study. The third study (13) concerned English 
patients admitted to a stroke rehabilitation unit. Of the 122 potential 
participants, 109 (89%) completed an assessment 3 weeks after stroke 
onset, and these data were used in the current study. Thus, the total 
number of English patients who fulfilled the inclusion criteria was 471, 
and the total number of participants was 420 (89%).
Measurements
Sociodemographic and clinical characteristics were obtained from 
medical records. The Dutch patients were assessed directly after ad-
mission to the rehabilitation centre. The physical therapists involved 
in the treatment of these patients completed the Dutch RMI for all 
participants, and the Dutch Barthel Index (BI) for a sub-sample of the 
participants. With respect to the first and second English studies (11, 
12) we used data from the baseline assessments, which were collected 
by research physiotherapists. The RMI of some participants could 
not be obtained at baseline in the acute phase after stroke in the third 
English study (13). We therefore used the RMI data from the 3-week 
follow-up assessment, which were collected by a research nurse.
The original English RMI is a PRO measure of mobility (Appendix 
1) (4). It is simple to use, clinically relevant, and has been well-tested, 
with satisfactory reliability, validity and responsiveness (4–10, 14–16). 
The RMI is an ordinal scale, consisting of 15 items addressing several 
aspects of mobility, and each item has 2 response options: yes or no. 
The sum scores range from 0 to 15, with higher scores indicating better 
mobility. The Dutch version of the RMI was translated by 2 bilingual 
and bicultural translators who were familiar with patients after stroke, 
in a double (back-) translation procedure (Appendix 2) (17). In order 
to make the RMI fully applicable in daily clinical practice (to be able 
to include patients with communication and cognitive problems) we 
slightly adapted the RMI instructions in the translation process: in the 
English RMI, except for one observer-based question, the assessor is 
instructed to ask the patient the questions (patient-reported), whereas 
in the Dutch RMI the assessor is instructed to observe the patient 
(observer-based).
The BI is a measure of mobility and personal care (18, 19), which 
is widely used and has been well-tested, and has been found to have 
satisfactory reliability, validity and responsiveness (7, 15, 19–21). The 
BI consists of 10 items, each of which has 2–4 possible responses. The 
sum scores for the BI range from 0 to 20, with higher values indicating 
better mobility and personal care.
Statistics
Patients. Differences in sociodemographic and clinical characteristics 
between the Dutch and the English patients were investigated with 
an independent samples t-test (age) and χ2 tests (gender and stroke 
location).
Unidimensionality and monotone homogeneity model fit. Unidimen-
sionality indicates that the items (questions) of a measurement instru-
ment assess one single underlying construct (22), whereas the fit of the 
items with the monotone homogeneity (MH) model implies that the 
items can be used for the measurement of patients (23–26).
We used Mokken scale analysis to investigate both unidimension-
ality and fit with the MH model of the RMI items (23–25). Mokken 
scale analysis can be considered as a non-parametric approach to item 
response theory (IRT). IRT is the class of psychometric models for 
scale construction that assumes that observed responses (answers) to 
items can be explained by a latent trait (variable), in our case mobility. 
Mokken scale analysis provides ordinal information about the loca-
tion of patients and items on the scale of the latent trait. Patients are 
ordered on this scale according to their sum scores: patients with higher 
sum scores have better mobility. Items are ordered on the scale of the 
latent trait according to their mean score, which is the proportion of 
patients who respond positively to the item. A positive response to an 
item with a low mean score indicates better mobility. 
Within the framework of Mokken scale analysis, unidimensional-
ity can be studied with the SEARCH procedure in the MSP software 
(24, 25). We investigated unidimensionality by stepwise increasing 
c, which is the lower bound for the scalability coefficient H (see 
below). According to Hemker et al. (27), a multidimensional item 
bank will often appear to form one scale at c = 0.30, while an item 
bank consisting of unidimensional scales will directly split into its 
unidimensional scales. At intermediate values of c (between 0.40 and 
0.60) a multidimensional scale will often break up into subscales. 
Beyond values of 0.80, unidimensional scales will also tend to split 
into their individual items.
Within the framework of Mokken scale analysis, the fit of the MH 
model is evaluated with the TEST procedure in the MSP software (24, 
25). MH model fit is evaluated by calculating the scalability coefficient 
H, which is a global indicator of the degree to which patients can be 
accurately ordered on the latent trait by means of their sum score. Scale 
criteria are met when: (i) the coefficients of scalability for all item pairs 
(Hij) are positive; (ii) the scalability coefficients for the items in rela-
tion to the scale at issue (Hi) are at least 0.30; and (iii) the scalability 
coefficient for the scale (H) is at least 0.30. Higher values for Hi and 
H imply a better scale. A rule of thumb is that a scale is considered 
to be strong when H ≥ 0.50, medium when 0.50 > H ≥ 0.40, and weak 
when 0.40 > H ≥ 0.30 (24, 25).
Differential item functioning. Differential item functioning (DIF), or 
item bias, addresses the issue of making valid comparisons between 
subgroups of patients. One may consider 2 subgroups of patients, for 
example Dutch and English patients after stroke, and assume that a cer-
tain item functions differently in these patients. In such a case, Dutch 
patients with the same true mobility as English patients may more 
often respond positively to this item, and they will then unintention-
ally tend to have higher scores than the English patients. So, an item 
that functions differently in subgroups of patients causes differences 
in subgroup scores, even when the patients in the subgroups have 
similar mobility. As a consequence, DIF impedes valid comparisons 
between these subgroups.
In this study we investigated DIF between the Dutch and the Eng-
lish RMI. Within the framework of Mokken scale analysis, DIF is 
studied by checking the assumption of equal ordering of the items on 
the scale of the latent trait. DIF is found if the ordering of the items 
is different within the subgroups that are investigated. For a detailed 
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check of DIF a diagnostic Crit value is calculated (24). No DIF is 
found if the largest Crit value per item is less than 40, but if the Crit 
value exceeds 80, DIF is suggested. DIF results can also be presented 
in the form of a scatter plot.
Intra-test reliability. Intra-test reliability (or internal consistency) 
assesses the degree of repeatability of the sum score. We quantified 
the intra-test reliability by calculating the reliability coefficient ρ (24, 
25). This is slightly superior to Cronbach’s α, which underestimates 
intra-test reliability when there is substantial variation in the level of 
mean scores per item (28). A reliability coefficient of 0.90 or more is 
recommended for stable decisions about individual patients (22).
Construct validity. Construct validity assesses the extent to which a 
particular measure relates to other measures consistent with theoreti-
cally derived hypotheses for the constructs that are being measured 
(22). We expected that the sum scores of the Dutch RMI and the Dutch 
BI would be strongly and positively correlated. Spearman’s correlation 
coefficient ρ was calculated to evaluate construct validity.
RESULTS
Patients
The mean (standard deviation (SD)) age of the Dutch patients 
was 58.6 (11.8) years; 102 (51%) were male. A supratento-
rial stroke had been sustained by 66 patients in the right 
hemisphere, and 91 patients in the left hemisphere. Forty-three 
patients had sustained an infra-tentorial stroke. The mean (SD) 
age of the English patients was 74.3 (9.2) years; 195 (46%) 
were male. A supratentorial stroke had been sustained by 203 
patients in the right hemisphere, and 213 patients in the left 
hemisphere. Four patients had sustained an infra-tentorial 
stroke. There were significant differences between the Dutch 
and the English patients in age (2-tailed p < 0.000) and loca-
tion of stroke (2-tailed p < 0.000), but not in gender (2-tailed 
p = 0.29). 
Unidimensionality
All the items in the combined Dutch-English data-set fitted 
in the scale, even at c = 0.80. This was also the case for the 
Dutch and English data-sets when they were tested separately. 
This indicates that the combined RMI, and the Dutch and the 
English RMI, are all strong unidimensional scales. 
Monotone homogeneity model fit
Scale criteria were met for all items in the combined Dutch-
English data-set and for both the Dutch and the English data-
sets when they were tested separately (Table I). For the 15 items 
in each of these 3 data-sets the coefficients of scalability for the 
item pairs (Hij) were all positive, the scalability coefficients for 
the items in relation to the scale at issue (Hi) were all greater 
than 0.30, and the scalability coefficients of the scales (H) 
were 0.91 for the combined Dutch-English data-set, 0.93 for 
the Dutch data-set, and 0.89 for the English data-set, indicating 
Table I. Item mean scores, coefficients of scalability of the items and the scale, coefficient of reliability and median (interquartile range) sum scores 
of the combined Dutch-English, Dutch and English Rivermead Mobility Index
Item 
No. Abbreviated text*
Combined
Dutch-English
(n = 620)
Dutch
(n = 200)
English
(n = 420)
Mean† Hi‡ Mean Hi Mean Hi
15. Running 0.04 1.00 0.12 1.00 0.00 §
14. Up and down four steps 0.09 0.96 0.21 0.97 0.03 0.92
12. Walking outside (uneven ground) 0.16 0.93 0.24 0.98 0.12 0.89
13. Bathing 0.20 0.87 0.32 0.90 0.14 0.84
9. Walking outside (even ground) 0.26 0.89 0.33 0.95 0.23 0.85
8. Stairs 0.27 0.87 0.37 0.91 0.23 0.84
10. Walking inside, with no aid 0.29 0.90 0.35 0.94 0.25 0.88
11. Picking off floor 0.31 0.92 0.34 0.94 0.29 0.90
7. Walking inside, with an aid if needed 0.44 0.95 0.46 0.97 0.43 0.94
6. Transfer 0.51 0.95 0.63 0.93 0.45 0.95
5. Standing unsupported 0.55 0.93 0.69 0.90 0.48 0.94
4. Sitting to standing 0.56 0.94 0.72 0.93 0.49 0.94
2. Lying to sitting 0.61 0.89 0.76 0.89 0.54 0.88
1. Turning over in bed 0.75 0.81 0.90 0.88 0.67 0.77
3. Sitting balance 0.75 0.86 0.93 0.92 0.67 0.84
Scalability coefficient H║ 0.91 0.93 0.89
Reliability coefficient ρ # 0.97 0.97 0.96
Sum score median** 5 6 3
Sum score interquartile range 1–10 3–12 1–9
*Abbreviated item text. The non-abbreviated item text can be found in Appendices 1 and 2.
†Item mean score, indicating the proportion of patients responding positively to the items. A positive response to an item with a low mean score 
indicates better mobility. 
‡Scalability coefficient Hi of the items in relation to the scale (range 0–1 under the monotone geneity (MH) model). A minimum value of Hi = 0.30 
is recommended.
§Scalability coefficient Hi could not be obtained because none of the English patients responded positively to this item.
║Scalability coefficient H for the scale (range 0–1 under the MH model). A scale is considered to be strong when H ≥ 0.50.
#Reliability coefficient ρ for the scale (range 0–1 under the MH model). ρ ≥ 0.90 is recommended for decisions about individual patients.
**Sum scores range from 0 to 15. Patients with higher sum scores have better mobility.
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strong scales. These results demonstrate that the RMI items 
can be used for the measurement of patients.
Differential item functioning
All Crit values were less than 40, and no DIF was found be-
tween the items of the Dutch and the English RMI (Fig. 1). 
This indicates that valid comparisons can be made between 
Dutch patients after stroke responding to the Dutch RMI and 
English patients responding to the English RMI.
Intra-test reliability
The intra-test reliability coefficient ρ was 0.97. This indicates that 
the intra-test reliability of the Dutch RMI was excellent, both for 
group descriptions and for decisions about individual patients.
Construct validity
The Dutch RMI sum score (median (interquartile range (IQR)) 
7 (4–13)) was strongly and positively correlated (Spearman’s 
correlation coefficient ρ = 0.84) with the Dutch BI sum score 
(median (IQR) 12 (9–17)) in a sub-sample of 91 patients. This 
indicates very good construct validity.
DISCUSSION
We investigated the cross-cultural validity of international 
Dutch-English comparisons when applying the Dutch RMI 
to patients after stroke. There were significant differences 
between the Dutch and the English patients after stroke with 
respect to age and stroke location. However, separate analyses 
(data not presented) demonstrated that age and stroke loca-
tion resulted in no difference in the order of the items, which 
implies that, despite these significant differences in age and 
stroke location, the cross-cultural validity of the Dutch RMI 
could be satisfactorily investigated in the current Dutch and 
English data-sets.
We studied unidimensionality and the item parameters of 
the Dutch and the English RMI with a Mokken scale analy-
sis, which is a non-parametric IRT method. In a similar study 
addressing the cross-cultural validity of the Western Ontario 
and McMaster Universities osteoarthritis index we used Rasch 
analysis (29), which is a more frequently used parametric IRT 
method (30–33). However, the advantages of a non-parametric 
IRT model are that response data will more easily fit with such 
a model and that the sum score is more easily understood. 
Moreover, because the RMI is an ordinal scale, we think 
that a non-parametric IRT model is more appropriate for this 
instrument.
In this study we demonstrated unidimensionality and an 
excellent fit with the MH model for both the Dutch and the 
English RMI, which implies that both versions do indeed 
measure a single construct (mobility), and that both are suitable 
for measuring patients after stroke. As far as we are aware, 
fit with the MH model has not previously been investigated 
for the RMI.
In order to study cross-cultural validity we used data-sets 
from 3 different English studies. One advantage of combining 
data-sets is that the scale analysis will result in better estimates 
of the scale parameters because of the larger number of patients 
included in the analysis. Moreover, in the current study, com-
bining the 3 data-sets resulted in a larger variation in patient 
mobility levels. A disadvantage might be that 3 "different" 
scales are combined. In an additional analysis (data not shown) 
we found excellent fit of the combined English RMI item set 
with the double monotonicity (DM) model from Mokken scale 
analysis (24, 25). Examples of studies addressing the DM fit of 
an item set are available from the literature (34, 35). Fit with 
the DM model indicates that the (hierarchical) ordering of 
the RMI items is the same for patients with different levels of 
mobility. Thus, combining different data-sets, even of patients 
with different levels of mobility, will not influence the order-
ing of the items. This implies that the cross-cultural validity 
of the Dutch RMI could be investigated in the 3 combined 
English data-sets.
We found no DIF between the Dutch RMI and the English 
RMI, which indicates that valid comparisons can be made 
between Dutch and English patients after stroke. Applying 
these results to the current data-sets, it can be shown that the 
Dutch patients after stroke had statistically significant higher 
RMI scores than the English patients (median (IQR): 6 (3–12) 
vs 3 (1–9); Mann-Whitney U test, 2-tailed p < 0.000) (Table I), 
and this may be related to the age difference between the 
2 groups. Our results enable researchers to pool data-sets, 
which were obtained with either the Dutch or the English 
Fig. 1. Mean item scores for Dutch patients after stroke responding to the 
Dutch Rivermead Mobility Index (RMI), and English patients after stroke 
responding to the English RMI. Mean scores for the Dutch and English 
patients are presented on the x and y axes, respectively. A positive response 
to an item with a low mean score indicates better mobility. The number 
above each data-point refers to the RMI item number (Table I). Items 
demonstrating differential item functioning would show major deviations 
from an imaginary line that can be drawn through the data-points.
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RMI. In addition, readers of international journals can make 
a straightforward comparison of scores on the Dutch and the 
English RMI. It should be mentioned here that changing the 
RMI from a patient-reported (English) into an observer-based 
(Dutch) instrument did not influence the ordering of the items 
in the Dutch and English samples that we studied.
The results of this study also demonstrated excellent intra-test 
reliability and construct validity of the Dutch RMI. However, 
we only studied intra-test reliability. Further studies should 
therefore address other aspects of reliability, such as intra-rater 
(or test-retest) reliability and inter-rater reliability. Further-
more, with regard to construct validity, we only studied the cor-
relation of the Dutch RMI with the Dutch BI. Construct validity 
should therefore be studied in more detail in future research. 
Finally, the responsiveness (or sensitivity to change) (36) of 
the Dutch RMI should also be studied in future research. We 
would, however, expect satisfactory results with respect to the 
clinimetric properties (reliability, validity and responsiveness), 
which have not been addressed in the current study, because, 
firstly, the original English RMI has good reliability, validity 
and responsiveness (4–10, 14–16) and, secondly, the results 
of the current study indicate the absence of DIF between the 
Dutch and the English RMI.
In summary, the Dutch RMI allows valid international 
Dutch-English comparisons, and has excellent intra-test reli-
ability and construct validity.
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APPENDIX 1. English version of the Rivermead Mobility Index
Instructions
The patient is asked the following 15 questions, but item 5 is observed. 
A score of 1 is given for each “yes” answer.
1.	 Turning over in bed
	 Do you turn over from your back to your side without help?
2.	 Lying to sitting
	 From lying in bed, do you get up to sit on the edge of bed on your 
own?
3.	 Sitting balance
	 Do you sit on the edge of the bed without holding on for 10 sec?
4.	 Sitting to standing
	 Do you stand up (from any chair) in less than 15 sec, and stand 
there for 15 sec (using hands, and with an aid if necessary)?
5.	 Standing unsupported
	 Observe standing for 10 sec without any aid.
6.	 Transfer
	 Do you manage to move from bed to chair and back without any 
help?
7.	 Walking inside, with an aid if needed
	 Do you walk 10 m, with an aid if necessary, but with no standby 
help?
8.	 Stairs
	 Do you manage a flight of stairs without help?
9.	 Walking outside (even ground)
	 Do you walk around outside, on pavements without help?
10.	 Walking inside, with no aid
	 Do you walk 10 m inside with no calliper, splint, or aid, and no 
standby help?
11.	 Picking off floor
	 If you drop something on the floor, do you manage to walk 5 m, 
pick it up and then walk back?
12.	 Walking outside (uneven ground)
	 Do you walk over uneven ground (grass, gravel, dirt, snow, ice, 
etc.) without help?
13.	 Bathing
	 Do you get in / out of bath or shower unsupervised and wash self?
14.	 Up and down four steps
	 Do you manage to go up and down four steps with no rail and 
without help, but using an aid if necessary?
15.	 Running
	 Do you run 10 m without limping in 4 sec (fast walk is 
acceptable)?
APPENDIX 2. Dutch version of the Rivermead Mobility Index
Instructie
De therapeut observeert de patiënt bij het uitvoeren van onderstaande 
activiteiten. Score 1 wordt gegeven voor iedere activiteit die 
zelfstandig kan worden uitgevoerd.
1.	 Omrollen in bed
	 Kan de patiënt in bed vanuit ruglig naar de zij rollen zonder 
hulp?
2.	 Van lig naar zit
	 Kan, de patiënt, als hij / zij in bed ligt, zonder hulp op de rand van 
het bed komen zitten?
3.	 Zitbalans
	 Kan de patiënt 10 tellen zonder steun of vast te houden op de 
rand van het bed zitten?
4.	 Van zit naar stand
	 Kan de patiënt vanuit een stoel binnen 15 sec komen staan en 
15 sec blijven staan (met gebruik van handen en / of hulpmiddel 
indien nodig)?
5.	 Stabalans
	 Kan de patiënt staan zonder steun gedurende 10 sec?
6.	 Transfer
	 Kan de patiënt van het bed naar de stoel komen en terug zonder 
hulp?
7.	 Lopen in huis, met hulpmiddel indien nodig
	 Kan de patiënt zelfstandig 10 m lopen, met hulpmiddel indien 
nodig?
8.	 Traplopen
	 Kan de patiënt zelfstandig de trap op en af lopen?
9.	 Lopen buiten, op effen terrein
	 Kan de patiënt buiten lopen, op het trottoir zonder hulp 
(eventueel met hulpmiddel)?
10.	 Lopen binnen zonder hulpmiddel
	 Kan de patiënt zelfstandig in huis lopen zonder hulpmiddel of 
orthese?
11.	 Iets oppakken van de grond
	 Als de patiënt iets op de grond laat vallen, kan hij / zij dan 5 m 
lopen, het voorwerp oppakken en weer terug lopen?
12.	 Lopen buiten, op oneffen terrein
	 Kan de patiënt buiten lopen op oneffen terrein (gras, grind, 
sneeuw, hellingen, stoepranden etc.) zonder hulp?
13.	 Baden / douchen
	 Kan de patiënt in en uit het bad / de douche komen en zichzelf 
wassen zonder hulp?
14.	 Vier treden op en af
	 Kan de patiënt vier treden op en af lopen zonder leuning, 
eventueel met gebruik van een loophulpmiddel?
15.	 Hardlopen
	 Kan de patiënt 10 m hardlopen binnen 4 sec (snelwandelen is 
toegestaan) in gelijk tred?
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